| Literature DB >> 21917233 |
I Bielsa1, F Benvenutti, R M Guinovart, C Ferrándiz.
Abstract
Scleromyxedema is a potentially serious disease that can have various systemic complications. One of the most frequent forms of central nervous system involvement is dermato-neuro syndrome. High-dose intravenous immunoglobulins are among the drug treatments that have been used for this syndrome. We describe 2 patients with scleromyxedema, one of whom developed dermato-neuro syndrome. Both patients responded well to treatment with high-dose intravenous immunoglobulins. We suggest this therapy as a suitable first-line treatment for scleromyxedema and for its neurological complications.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21917233 DOI: 10.1016/j.ad.2011.04.015
Source DB: PubMed Journal: Actas Dermosifiliogr ISSN: 0001-7310